92 related articles for article (PubMed ID: 21261689)
1. Haematological malignancies: the rationale for integrated haematopathology services, key elements of organization and wider contribution to patient care.
Ireland R
Histopathology; 2011 Jan; 58(1):145-54. PubMed ID: 21261689
[TBL] [Abstract][Full Text] [Related]
2. Haematological cancers: improving outcomes. A summary of updated NICE service guidance in relation to Specialist Integrated Haematological Malignancy Diagnostic Services (SIHMDS).
Snowden JA; O'Connell S; Hawkins J; Dalley C; Jack A; Mannari D; McNamara C; Scott M; Shenton G; Soilleux E; Macbeth F;
J Clin Pathol; 2017 Jun; 70(6):461-468. PubMed ID: 28389440
[TBL] [Abstract][Full Text] [Related]
3. The development of haematopathology laboratories: a possible model for other pathology services.
Jack AS; Morgan GJ
J Pathol; 1998 Mar; 184(3):231-3. PubMed ID: 9614372
[TBL] [Abstract][Full Text] [Related]
4. Implementation of the updated NICE haematological cancers (NG47) improving outcomes guidelines across Specialist Integrated Haematological Malignancy Diagnostic Services (SIHMDS) in England: a UK NEQAS LI survey.
Cartwright A; Snowden JA; Whitehouse H; Scott S; Whitby L
J Clin Pathol; 2023 Sep; 76(9):618-623. PubMed ID: 35508367
[TBL] [Abstract][Full Text] [Related]
5. Specialist integrated haematological malignancy diagnostic services: an Activity Based Cost (ABC) analysis of a networked laboratory service model.
Dalley C; Basarir H; Wright JG; Fernando M; Pearson D; Ward SE; Thokula P; Krishnankutty A; Wilson G; Dalton A; Talley P; Barnett D; Hughes D; Porter NR; Reilly JT; Snowden JA
J Clin Pathol; 2015 Apr; 68(4):292-300. PubMed ID: 25631214
[TBL] [Abstract][Full Text] [Related]
6. Organisation of neoplastic haematopathology services: a UK perspective.
Jack A
Pathology; 2005 Dec; 37(6):479-92. PubMed ID: 16373228
[TBL] [Abstract][Full Text] [Related]
7. The NCI All Ireland Cancer Conference.
Johnston PG; Daly PA; Liu E
Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862
[TBL] [Abstract][Full Text] [Related]
8. Procedures and methods of benefit assessments for medicines in Germany.
Bekkering GE; Kleijnen J
Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
[TBL] [Abstract][Full Text] [Related]
9. Synoptic tool for reporting of hematological and lymphoid neoplasms based on World Health Organization classification and College of American Pathologists checklist.
Mohanty SK; Piccoli AL; Devine LJ; Patel AA; William GC; Winters SB; Becich MJ; Parwani AV
BMC Cancer; 2007 Jul; 7():144. PubMed ID: 17672904
[TBL] [Abstract][Full Text] [Related]
10. [Procedures and methods of benefit assessments for medicines in Germany].
Bekkering GE; Kleijnen J
Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813
[TBL] [Abstract][Full Text] [Related]
11. Meeting the needs of parents around the time of diagnosis of disability among their children: evaluation of a novel program for information, support, and liaison by key workers.
Rahi JS; Manaras I; Tuomainen H; Hundt GL
Pediatrics; 2004 Oct; 114(4):e477-82. PubMed ID: 15466074
[TBL] [Abstract][Full Text] [Related]
12. Haematological cancers: improving outcomes. A summary of updated NICE service guidance in relation to Specialist Integrated Haematological Malignancy Diagnostic Services (SIHMDS).
Cuthbert RJG
J Clin Pathol; 2017 Jun; 70(6):469. PubMed ID: 28389439
[No Abstract] [Full Text] [Related]
13. [Clinical uses of flow cytometry in hematological oncology].
D'Ostilio A; Ginaldi L; Marini L; Di Gennaro A; De Martinis M; Quaglino D
Recenti Prog Med; 1997 Apr; 88(4):157-65. PubMed ID: 9206811
[TBL] [Abstract][Full Text] [Related]
14. National Cancer Patient Registry--Haematology Malignancy (NCPR-HM).
Chang KM; Ong TC
Med J Malaysia; 2008 Sep; 63 Suppl C():66-7. PubMed ID: 19227675
[TBL] [Abstract][Full Text] [Related]
15. Care of the haematology patient and their family--the GP viewpoint.
McGrath P
Aust Fam Physician; 2007 Sep; 36(9):779-81, 784. PubMed ID: 17885718
[TBL] [Abstract][Full Text] [Related]
16. Genetic lesions and the malignant phenotype of haematological cancers.
Vandenberghe P
Verh K Acad Geneeskd Belg; 2007; 69(5-6):291-313. PubMed ID: 18351210
[TBL] [Abstract][Full Text] [Related]
17. Family planning operations research in Africa: reviewing a decade of experience.
Wawer MJ; McNamara R; McGinn T; Lauro D
Stud Fam Plann; 1991; 22(5):279-93. PubMed ID: 1759274
[TBL] [Abstract][Full Text] [Related]
18. [Computerization and the importance of information in health system, as in health care resources registry].
Troselj M; Fanton D
Acta Med Croatica; 2005; 59(3):251-7. PubMed ID: 16095200
[TBL] [Abstract][Full Text] [Related]
19. Putting National Institute for Health and Clinical Excellence guidance into practice: a cost minimization model of a national roll-out of liquid based cytology in England.
Stoykova B; Kuzmanov G; Dowie R
Int J Technol Assess Health Care; 2008; 24(4):391-8. PubMed ID: 18828932
[TBL] [Abstract][Full Text] [Related]
20. [Proteomics techniques and their application in haemato-oncologic malignancies].
Zelená J; Hájek R
Cas Lek Cesk; 2007; 146(7):586-92. PubMed ID: 17722845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
